ABSTRACT
Objective To develop a predictive model for early recurrence after surgery for oesophageal adenocarcinoma using a large multi-national cohort.
Summary Background Data Early cancer recurrence after oesophagectomy is a common problem with an incidence of 20-30% despite the widespread use of neoadjuvant treatment. Quantification of this risk is difficult and existing models perform poorly. Machine learning techniques potentially allow more accurate prognostication and have been applied in this study.
Methods Consecutive patients who underwent oesophagectomy for adenocarcinoma and had neoadjuvant treatment in 6 UK and 1 Dutch oesophago-gastric units were analysed. Using clinical characteristics and post-operative histopathology, models were generated using elastic net regression (ELR) and the machine learning methods random forest (RF) and XG boost (XGB). Finally, a combined (Ensemble) model of these was generated. The relative importance of factors to outcome was calculated as a percentage contribution to the model.
Results In total 812 patients were included. The recurrence rate at less than 1 year was 29.1%. All of the models demonstrated good discrimination. Internally validated AUCs were similar, with the Ensemble model performing best (ELR=0.785, RF=0.789, XGB=0.794, Ensemble=0.806). Performance was similar when using internal-external validation (validation across sites, Ensemble AUC=0.804). In the final model the most important variables were number of positive lymph nodes (25.7%) and vascular invasion (16.9%).
Conclusions The derived model using machine learning approaches and an international dataset provided excellent performance in quantifying the risk of early recurrence after surgery and will be useful in prognostication for clinicians and patients.
DRAFT VISUAL ABSTRACTIcons taken from www.flaticon.com, made by ‘Freepik’, ‘smashicons’, and ‘prettycons’. Reproduced under creative commons attribution license
MINI-ABSTRACT Early recurrence after surgery for adenocarcinoma of the oesophagus is common. We derived a risk prediction model using modern machine learning methods that accurately predicts risk of early recurrence using post-operative pathology
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No direct funding was recieved for this project. TJU is supported by a Cancer Research UK and Royal College of Surgeons of England Advanced Clinician Scientist Fellowship, ID:A23924 OCCAMS2 was funded by a Programme Grant from Cancer Research UK (RG81771/84119)
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
NA
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Footnotes
Disclosures and Funding: The authors present no conflicts of interest.
TJU is supported by a Cancer Research UK and Royal College of Surgeons of England Advanced Clinician Scientist Fellowship, ID:A23924, OCCAMS2 was funded by a Programme Grant from Cancer Research UK (RG81771/84119)
Data Availability
Data referred to in the manuscript was collected in the specified centres as part of local quality assurance and the OCCAMS project and remains property of those institutions
